Search Results - person:"Guilarte, Mar"

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Blasco, Antonio J.; Lázaro, Pablo; Caballero, Teresa; … - In: Health Economics Review 3 (2013) 2, pp. 1-11

Background: Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe. Aim: To compare the economic impact of two icatibant administration strategies: health...

Persistent link: https://www.econbiz.de/10010317154

La regulación del shadow banking en el contexto de la reforma del mercado financiero

Marimón Durá, Rafael; Galán López, Carmen; León … - 2015 - Primera edición

Persistent link: https://www.econbiz.de/10011480001

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Blasco, Antonio J.; Lázaro, Pablo; Caballero, Teresa; … - In: Health economics review 3 (2013) 2, pp. 1-11

Persistent link: https://www.econbiz.de/10009755347

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Blasco, Antonio; Lázaro, Pablo; Caballero, Teresa; … - In: Health Economics Review 3 (2013) 1, pp. 1-11

Costs related to the management of acute HAE attacks with C1 inhibitor deficiency may be substantially reduced through interventions targeting home treatment by training patients to self-administer icatibant. </AbstractSection> Copyright Blasco et al; licensee Springer. 2013

Persistent link: https://www.econbiz.de/10010998831

Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain

Blasco, Antonio J.; Lázaro, Pablo; Caballero, Teresa; … - In: Health economics review 3 (2013) 2, pp. 1-11

Persistent link: https://www.econbiz.de/10010148175